"Tratamientos","2023","2024","2025"
"Sunitinib",100,100,100
"Pembrolizumab + Axitinib",0,0,0
"Pembrolizumab + Lenvatinib",0,0,0
"Nivolumab + Cabozantinib",0,0,0
"Nivolumab + Ipilimumab",0,0,0
"Avelumab + Axitinib",0,0,0
